Rashesol® | Prescription rash relief
Made in America Fragrance Free Ships out in 24 hours

Rashesol® | Prescription rash relief

Oncoderm’s Rashesol® prescription rash relief is formulated to reduce extreme inflammation of the skin due to side effects from cancer treatment. Using a highly potent corticosteroid mixed in a naturally soothing, plant-powered base, this lightweight, non-greasy prescription-strength micro-mist spray was designed to calm, hydrate and heal large areas of the body. 

Formulated by pharmacists and dermatologists for sensitive skin.

Active Ingredient: Clobetasol 0.05%

100% Fragrance-free. Non-comedogenic. Hypoallergenic. 

CALL US to order this affordable Oncoderm prescription: 844-468-9244

Formulated to relieve rashes

Using a highly potent corticosteroid in a plant-powered natural base, this lightweight, non-greasy, prescription-strength micro-mist spray was designed by doctors to hydrate and soothe large areas of the body.

Frequently Asked Questions
Currently, our prescription products are available to residents of Alaska, Arizona, California, Colorado, Connecticut, Delaware, Florida, Hawaii, Illinois, Iowa, Kansas, Kentucky, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Jersey, New Mexico, New York, North Dakota, Ohio, Oregon, Pennsylvania, Rhode Island, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin and Wyoming with additional coverage coming soon.
Mass-produced medication, while good for some, isn’t ideal for everyone. People undergoing cancer treatment typically have more sensitive immune systems, skin, hair, and nails than the general population. That’s why we started Oncoderm—to offer safe, effective solutions for people living with cancer at prices they could afford.
With some of the so-called “targeted therapies” (bortezomib, cetuximab, erlotinib, gefitinib, and panitumumab), the development of a rash means the medication is having a greater anti-cancer effect. However, people who don’t develop a rash can still benefit from these medicines. For those who do develop a rash, treating it will not reduce the beneficial effect of the targeted treatment. In fact, managing the rash prevents discomfort and reduces the chance of having to change or stop your targeted therapy.